What does the evidence say about Chromium Appetite Randomized Trial?

The current Migaku evidence database contains 2 reusable source documents for Chromium Appetite Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation. - Mineral supplementation was associated with significant reductions in fasting blood glucose (SMD = − 0.34, p < 0.001), fasting insulin (SMD = − 0.72, p < 0.001), and HOMA-IR (SMD = − 0.75, p < 0.001). [Ye J (2026); evidence level 1] - In addition, total cholesterol (SMD = − 0.35, p < 0.001) and triglyceride levels (SMD = − 0.58, p < 0.001) were significantly reduced. [Ye J (2026); evidence level 1] - CONCLUSION: Mineral supplementation may improve insulin resistance and selected metabolic parameters in PCOS, with the most consistent effects observed for glycemic indices. [Ye J (2026); evidence level 1] - BACKGROUND: Polycystic ovary syndrome (PCOS) often leads to insulin resistance, affecting glucose and fat metabolism. [Ye J (2026); evidence level 1] - They are used to meet daily nutrient requirements, support physiological functions, and address increased nutritional needs, including in special populations. [Nawathe V (2026); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.